Glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1 RA) Semaglutide and Tirzepatide, dual GIP/GLP-1 receptor agonists, have shown significant efficacy in reducing body weight and improving glucose control (Jastreboff et al
The combination was associated with improvements not only in joint and skin disease, but also in weight, physical function, and quality of life
Muscle is critical for maintaining a healthy metabolic rate and physical function
Comparing Thrive GLP-1 to prescription medications Direct comparison between Thrive GLP-1 and prescription medications reveals dramatic differences in effectiveness, cost, administration, side effects, and appropriate use cases
Research shows that roughly 30 to 50 grams of protein per sitting produces a strong anabolic response